ProteoSys AG
Industry
- Pharmaceuticals
- In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Biotechnology
- Drug Discovery Technologies
- Genomics-Proteomics
- Drug Discovery Technologies
Latest on ProteoSys AG
Investments for start-ups seeking their first infusion of venture capital continue to be scarce as venture firms seek later-stage opportunities and liquidity to improve their own chances of raising ne
Index Ventures on October 27 pledged up to €10 million ($13.4 million) to Swiss start-up Mind-NRG SA in the latest example of the venture capitalist's asset-centric financing model. [See Deal] T
In Vitro Diagnostics Acquisitions / In Vitro Diagnostics Becton Dickinson & Co. US Genomics Inc. US Genomics (technologies for diagnostics and biodefense applications) and Becton Dickinson seek t
by Beth Detuzzi Abbott Spine (a division of Abbott Laboratories Inc.) & Zimmer Holdings Inc. Zimmer Holdings is paying $360mm in cash to acquire Abbott Spine (devices to treat spinal diseases),